[1] |
World Health Organization . Global tuberculosis report 2017. Geneva:World Health Organization, 2017.
|
[2] |
宋言峥 . 重视肺结核的外科治疗. 中国肺癌杂志, 2018,21(4):323-326.
|
[3] |
宋言峥 . 不应忽视外科在控制结核病传染源中的作用. 中国防痨杂志, 2017,39(1):6-10.
doi: 10.3969/j.issn.1000-6621.2017.01.005
URL
|
[4] |
World Health Organization . Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2008: 67-68.
URL
pmid: 21828024
|
[5] |
World Health Organization . WHO treatment guidelines for drug-resistant tuberculosis, 2016 Update. Geneva: World Health Organization, 2016: 37-39.
URL
pmid: 27748093
|
[6] |
Pfyffer GE, Welscher HM, Kissling P , et al. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol, 1997,35(2):364-368.
|
[7] |
Yam WC, Yuen KY, Kam SY , et al. Diagnostic application of genotypic identification of mycobacteria. J Med Microbiol, 2006,55(Pt 5):529-536.
doi: 10.1099/jmm.0.46298-0
URL
pmid: 16585639
|
[8] |
张舒林, 王洪海 . 结核分枝杆菌特异性抗原检测的研究现状及展望. 中国热带医学, 2008,8(2):299-301.
doi: 10.3969/j.issn.1009-9727.2008.02.066
URL
|
[9] |
Parkash O, Singh BP, Pai M . Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans. Scand J Immunol, 2009,70(4):345-357.
doi: 10.1111/j.1365-3083.2009.02312.x
URL
pmid: 19751269
|
[10] |
Liu C, Zhao Z, Fan J , et al. Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. Proc Natl Acad Sci U S A, 2017,114(15):3969-3974.
doi: 10.1073/pnas.1621360114
URL
|
[11] |
Ozbek A, Aktas O . Identification of three strains of Mycobacterium species isolated from clinical samples using fatty acid methyl ester profiling. J Int Med Res, 2003,31(2):133-140.
doi: 10.1177/147323000303100210
URL
pmid: 12760317
|
[12] |
Raju RM, Raju SM, Zhao Y , et al. Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerg Infect Dis, 2016,22(3):365-369.
doi: 10.3201/eid2203.151643
URL
pmid: 26886068
|
[13] |
Hoefsloot W, van Ingen J, Andrejak C , et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J, 2013,42(6):1604-1613.
doi: 10.1183/09031936.00149212
URL
pmid: 23598956
|
[14] |
Pang Y, Tan Y, Chen J , et al.Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J, 2017, 49(3).pii: 1601429.
|
[15] |
Chien JY, Lai CC, Sheng WH , et al. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000—2012. Emerg Infect Dis, 2014,20(8):1382-1385.
doi: 10.3201/eid2008.131673
URL
pmid: 4111185
|
[16] |
Mirsaeidi M, Farshidpour M, Allen MB , et al. Highlight on advances in nontuberculous mycobacterial disease in North America. Biomed Res Int, 2014,2014:919474.
doi: 10.1155/2014/919474
URL
pmid: 25574470
|
[17] |
Cole ST, Brosch R, Parkhill J , et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998,393(6685):537-544.
|
[18] |
Somoskovi A, Parsons LM, Salfinger M . The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res, 2001,2(3):164-168.
|
[19] |
Zhao JR, Bai YJ, Zhang QH , et al. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis, 2005,51(2):135-137.
|
[20] |
Boehme CC, Nabeta P, Hillemann D , et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010,363(11):1005-1015.
|
[21] |
Kebede A, Demisse D, Assefa M , et al. Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level. BMC Res Notes, 2017,10(1):661.
doi: 10.1186/s13104-017-2989-7
URL
pmid: 29191227
|